Form 8.3 - DECHRA PHARMACEUTICALS PLC

Barclays PLC
14 November 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

DECHRA PHARMACEUTICALS PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

13 Nov 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

1p ordinary

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

7,468,068

6.56%

1,844,483

1.62%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

1,179,952

1.04%

7,397,096

6.49%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

0

0.00%

0

0.00%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

8,648,020

7.59%

9,241,579

8.11%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

1p ordinary

Purchase

21,428

37.8025  GBP

1p ordinary

Purchase

21,279

37.8023  GBP

1p ordinary

Purchase

13,693

37.8619  GBP

1p ordinary

Purchase

1,510

37.8583  GBP

1p ordinary

Purchase

1,429

37.8543  GBP

1p ordinary

Purchase

907

37.8448  GBP

1p ordinary

Purchase

756

37.8558  GBP

1p ordinary

Purchase

753

37.8573  GBP

1p ordinary

Purchase

524

37.8400  GBP

1p ordinary

Purchase

388

37.8600  GBP

1p ordinary

Purchase

383

37.8598  GBP

1p ordinary

Purchase

346

37.7800  GBP

1p ordinary

Purchase

200

37.8800  GBP

1p ordinary

Purchase

107

37.8500  GBP

1p ordinary

Purchase

51

37.9000  GBP

1p ordinary

Sale

6,102

37.8620  GBP

1p ordinary

Sale

3,310

37.8176  GBP

1p ordinary

Sale

2,560

37.8478  GBP

1p ordinary

Sale

1,252

37.8400  GBP

1p ordinary

Sale

416

37.7800  GBP

1p ordinary

Sale

107

37.8500  GBP

1p ordinary

Sale

68

37.8600  GBP

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

1p ordinary

SWAP

Long

2,560

37.8478  GBP

1p ordinary

SWAP

Long

4,306

37.8227  GBP

1p ordinary

CFD

Short

18

37.8133  GBP

1p ordinary

SWAP

Short

107

37.8500  GBP

1p ordinary

SWAP

Short

169

37.8800  GBP

1p ordinary

SWAP

Short

323

37.8129  GBP

1p ordinary

SWAP

Short

383

37.8598  GBP

1p ordinary

SWAP

Short

2,575

37.8348  GBP

1p ordinary

SWAP

Short

2,871

37.7800  GBP

1p ordinary

SWAP

Short

3,601

37.8609  GBP

1p ordinary

SWAP

Short

4,000

37.7837  GBP

1p ordinary

SWAP

Short

5,009

37.8029  GBP

1p ordinary

SWAP

Short

9,940

37.7830  GBP

1p ordinary

SWAP

Short

13,693

37.8619  GBP

1p ordinary

SWAP

Short

13,739

37.8066  GBP

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i)  the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

14 Nov 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings